0001209191-22-042039.txt : 20220713
0001209191-22-042039.hdr.sgml : 20220713
20220713160552
ACCESSION NUMBER: 0001209191-22-042039
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220711
FILED AS OF DATE: 20220713
DATE AS OF CHANGE: 20220713
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ramasastry Saira
CENTRAL INDEX KEY: 0001547959
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39083
FILM NUMBER: 221081143
MAIL ADDRESS:
STREET 1: 501 CANAL BLVD.
CITY: RICHMOND
STATE: CA
ZIP: 94804
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vir Biotechnology, Inc.
CENTRAL INDEX KEY: 0001706431
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 812730369
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 499 ILLINOIS STREET
STREET 2: SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-906-4324
MAIL ADDRESS:
STREET 1: 499 ILLINOIS STREET
STREET 2: SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-07-11
0
0001706431
Vir Biotechnology, Inc.
VIR
0001547959
Ramasastry Saira
C/O VIR BIOTECHNOLOGY, INC.
499 ILLINOIS STREET, STE 500
SAN FRANCISCO
CA
94158
1
0
0
0
Common Stock
2022-07-11
4
A
0
5000
12.76
A
13092
D
Common Stock
2022-07-11
4
S
0
5000
30.00
D
8092
D
Stock Option (Right to Buy)
12.76
2022-07-11
4
M
0
5000
0.00
D
2029-12-09
Common Stock
5000
42777
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 28, 2022.
1/3 of the shares subject to the stock option vested and became exercisable on September 4, 2020, and the remaining shares vest in 24 equal monthly installments thereafter.
/s/ Howard Horn, Attorney-in-Fact
2022-07-12